Resapp Health Ltd operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Resapp Health Ltd with three other
pharmaceutical manufacturers in Australasia:
sales of 152,317.26 Australian Dollars [US$122,048.77 ]
MGC Pharmaceuticals Ltd
(247,500.00 Australian Dollars [US$198,316.80 ]
Prescient Therapeutics Ltd
(166,220.00 Australian Dollars [US$133,188.76 ]
Resapp Health Ltd reported sales of A$204,317.00 (US$163.72 thousand)
June of 2017.
increase of 147.3%
versus 2016, when the company's sales were A$82,633.00 .